Beginner's Mind

Beginner's Mind

Download on the App Store

All Beginner's Mind episodes

  • MM4: Philipp Baaske - From Science Fiction to Microgravity: Nanotemper's Journey to the International Space Station

    Discover the groundbreaking journey of Nanotemper Technologies as CEO Philipp Baaske shares his passion for space exploration, science fiction, and the company's ambitious project aboard the International Space Station. Learn how microgravity is poised to revolutionize biotech research and redefine our understanding of protein stability. Don't miss this exclusive conversation with one of the most innovative minds in the industry!

    Quote:
    (02:44) "To really understand what temperature alone does to [antibodies] without flows, you have to switch off gravity, which you can't do on Earth. But on the International Space Station, with microgravity, there's nearly no influence of gravity, so we can study the stability of antibodies without the influence of gravity or thermal convective flows."

    ⏰ Timestamps
    (00:44) Passion for Space Exploration: Star Trek, Star Wars, and SpaceX
    (03:25) Organizing a Space Project: Collaboration and Opportunities
    (05:16) Pursuing Exciting Projects for Fun and Scientific Advancement
    (06:39) Inspirations from Science Fiction: Isaac Asimov's Lucky Star

    Watch the full video:

    💡 LINKS TO MORE CONTENT
    Podcast: https://beginnersmind.buzzsprout.com/779930/12585340
    Philipp Baaske: https://www.linkedin.com/in/philipp-baaske/
    Christian Soschner: https://www.linkedin.com/in/christiansoschner/

    #nanotemper #spaceexploration #microgravity #philippbaaske

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    11 min
  • SP 7: From Villains to Vision: Unlocking Elon Musk's Powerwall Presentation Genius

    Discover the secrets behind Elon Musk's captivating Powerwall presentation and learn how to engage your audience like a true visionary! Another special episode on the podcast unmasking presentation secrets.

    In this episode, we dive deep into the art of storytelling, persuasion, and communication used by Musk during his groundbreaking Tesla Powerwall speech. Uncover the key techniques that made this presentation so influential and explore how you can apply them to captivate your own audience. 🚀

    🔹 Time Markers:
    (00:36) Introduce a Villain
    (01:15) Agitate the Problem
    (01:51) Spark Intrigue
    (02:26) Offer the Missing Piece of the Puzzle
    (02:44) Show, Don't Tell
    (04:12)Sell Benefits, Not Features
    (05:01) Create Urgency
    (05:46) Build Trust
    (06:43) Demonstrate the Potential
    (08:02) Show Your Long-Term Vision

    Youtube video:  https://youtu.be/6YpO3XS_x8U

    By analyzing these powerful moments, we'll unlock the keys to Elon Musk's presentation success. Learn how to inspire, educate, and captivate your audience, just like the Tesla CEO himself. 

    Don't miss this opportunity to transform your own presentations and make a lasting impact! 🌍🔋

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    10 min
  • MM3: Jeevan Sunner - Powerful Voices: The Rise of Female Leaders in Tech and Venture Capital

    In this captivating episode of our podcast, we address the pressing issue of gender diversity within the tech and venture capital sectors, inviting Jeevan Sunner, a distinguished investor from Playfair Capital, to share her invaluable insights on the matter. Jeevan emphasizes the importance of promoting female representation in the industry and explores the vast opportunities that can arise from embracing diverse perspectives.

    As CEOs and investors, understanding the immense value of nurturing a more inclusive environment is essential to unlock the full potential of the tech sector and maximizing investment returns. This episode sheds light on the challenges faced by women in tech and venture capital and discusses the actions that can be taken to create a more equitable landscape.

    Tune in to this enthralling conversation and learn how your organization can foster change and benefit from increased diversity in the tech and venture capital fields. Don't miss this chance to listen to a leader who is spearheading the movement for inclusivity and championing the transformative power of gender equality in the tech world.

    Subscribe to our podcast and stay informed on the latest trends and insights that will help you navigate the ever-evolving landscape of the tech and venture capital industries.

    Link to full episode

    ⏰ Timestamps
    (00:00) Intro
    (01:00) Jeevan Sunner talks about the Gender GAP in the Startup World

    💡 LINKS TO MORE CONTENT
    If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
    Watch on Youtube
    Jeevan Sunner
    Christian Soschner

    Support the show

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    9 min
  • #110: DC Palter - From Japan to Silicon Valley: A Unique Business Angel Journey

    Unlock the secrets to startup success! Dive into an engaging conversation with DC Palter, a seasoned startup founder, CEO, and angel investor, as he shares invaluable insights and advice for CEOs and investors. Explore resilience, Japanese culture's impact on business, and innovative strategies. Don't miss out!

    💡 LINKS TO MORE CONTENT
    Check out our partners
    Youtube
    Christian Soschner
    Today’s speaker is DC Palter

    📚 Book mentions in the episode:
    To Kill a Unicorn
    The Power Law

    📖 Memorable Quotes:
    (14:42) "We need to think outside the box, have a goal, a dream; sometimes it works out spectacularly, and a lot of times it doesn't, but we tried and that's the building blocks for the next one."
    (42:23) "The number that's always quoted is “90% will fail”, but that doesn't mean fail outright. That means not succeeding as expected. About half of those will actually fail outright and give you no return, and then another four will give you something like your money back, maybe a little bit more, maybe a little bit less. So we call that a failure anyway, even though they haven't really completely failed."
    (01:01:56) "You can have a really simple idea, but if you have a lot of customers for it, if you know how to market it and build up a brand name, you can make a lot of money – and that's what investors are looking for."
    (1:27:57) "Marketing is about understanding the business, the market, and the customers, and becoming part of that community, so that customers find you."
    (1:48:07) “Embrace resilience, for every day is a challenge. You may be familiar with the English expression, 'three steps forward, two steps back.' However, in the world of startups, it's more like taking three steps forward and 2.9 steps back. Indeed, each day is a roller coaster ride.”

    ⏰ Timestamps:
    (01:46) Tea Ceremony, Japanese Culture, and Shared Interests
    (05:15) Who is Satoshi Nakamoto?
    (06:39) Silicon Valley Life, Work, and Writing Experience
    (07:22) Arnold Schwarzenegger and the Startup World
    (13:00) Tesla's Success: Overcoming Skepticism in Electric Vehicles 
    (16:21) Theranos: Fake it Till You Make It
    (20:04) The Valley of Death: Challenges in Raising Money for Hard Tech Startups
    (24:42) Defining Financial Investor: Angel vs. Venture Capitalist 
    (29:03) Investing in Startups: Balancing Personal Interests and Group Expertise
    (36:56) Uncovering success in the startup landscape 
    (41:57) The long game of angel investing and managing expectations
    (48:23) The Mindset and Motivations of Angel Investors 
    (56:34) Key Advantages of Angel Investments and Avoiding Startup Pitfalls
    (01:01:59) Crafting the perfect pitch: focus on product, market, and customers 
    (01:07:09) Diversifying startup funding: alternatives to venture capital
    (1:12:12) Unraveling a Startup's Dark Secret: Discovering the True Intentions of Super Duper
    (1:19:20) Unexpected Love Triangle: Complex Relationships Amidst a Mysterious Investigation
    (1:24:05) The Importance of Social Media in B2B Marketing 
    (1:29:57) Building an Effective Following and its Impact on Business
    (1:35:51) Building a Community on LinkedIn and Medium 
    (1:39:04) Medium's Future: Business Model and Sustainability Concerns
    (1:48:00) Message to Startup Founders


    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    1 hr 53 min
  • #109: Philipp Baaske (NanoTemper) - Sell It Before You Build It

    NanoTemper’s first customer paid for an instrument that did not yet exist.

    Philipp Baaske and his co-founder used that payment to buy the parts, build the device and deliver it. The proceeds helped fund the next two instruments. By the time of this conversation, their company had grown to 237 people across 30 nationalities.

    The breakthrough followed roughly 30 failed demonstrations and a late-night experiment just before Christmas.

    Philipp Baaske, co-founder of NanoTemper Technologies, joins Christian Soschner to explain how a discovery during his PhD became a global business supplying tools for drug discovery and protein research.

    We explore the choices behind that growth: finding paying customers, choosing between bootstrapping and venture capital, understanding the problem behind a product request, and giving talented people the freedom to work.

    Philipp also shares the personal side of building a company: teachers who underestimated him, the curiosity that pushed him beyond his village, and the founder’s ego that can become an obstacle to growth.

    Originally released in April 2023. Company figures and project plans reflect the conversation at that time.

    WHAT YOU WILL LEARN

    • How NanoTemper’s first customer helped finance its first instruments.
    • Why scientific founders can get stuck developing technology instead of selling a product.
    • What bootstrapping and venture capital mean for a founder’s freedom.
    • How to uncover the real need behind a customer’s requested solution.
    • Why hiring people better than you requires changing your own behavior.
    • How to define an angel investor’s role before expectations collide.

    MEMORABLE QUOTES

    (01:10:05) “Sell the device, sell the product before you have it.”

    (01:23:09) “My own ego was my biggest hurdle to overcome.”

    (01:39:40) “Micromanagement can be a symptom or sign for fear.”

    TIMESTAMPS

    (00:00:00) Introduction: From scientific discovery to a global business
    (00:03:09) Silicon Valley Bank: Focus on what you can influence
    (00:07:03) Starting NanoTemper during the 2008 financial crisis
    (00:11:58) Scaling to 237 people across 30 nationalities
    (00:13:19) Leading a global team through trust
    (00:15:25) Hiring mistakes and the limits of a founder’s gut feeling
    (00:21:04) Creating scientific messaging that customers remember
    (00:23:34) Turning a PhD discovery into a business opportunity
    (00:26:15) The first sale: A customer pays before the instrument exists
    (00:29:11) Bootstrapping or venture capital: Choosing your route
    (00:33:28) The customer breakthrough that made the work feel worthwhile
    (00:35:53) Find the customer’s problem before designing the solution
    (00:39:41) Why competitors can be evidence of a real market
    (00:42:36) New opportunities in protein research and drug discovery
    (00:46:25) Why starting risky projects can be harder than stopping them
    (00:49:01) Underestimated at school: The teacher who got it wrong
    (00:50:54) Letting curiosity overcome fear of the unfamiliar
    (00:53:53) How co-founders, mentors and partners help you move forward
    (00:55:31) What a farming family taught Philipp about entrepreneurship
    (01:01:11) Planning protein experiments for the International Space Station
    (01:03:52) The scientific freedom of an independent company
    (01:08:01) Why technical founders need to focus on sales
    (01:11:58) Three years without a customer: What kept the founders going
    (01:13:41) Why better research tools matter to patients
    (01:19:40) A customer’s assay challenge: Three months versus two days
    (01:21:41) Leadership starts with changing yourself
    (01:28:49) Giving honest feedback and admitting your mistakes
    (01:36:53) When product launches outpace your own organization
    (01:38:00) Founder insecurity and the urge to micromanage
    (01:40:46) What a supportive business angel can give a founder
    (01:44:04) Difficult departures and protecting the team
    (01:50:00) Defining the angel investor’s role and expectations
    (01:58:18) Final advice: Reconsider what used to be impossible

    CONTINUE THE CONVERSATION

    Join the Beginner’s Mind newsletter for ideas on building companies, investing and leadership:
    https://lsg2g.substack.com/subscribe





    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    2 hr 4 min
  • MM 2: The Shocking Truth Behind Declining Drug R&D Productivity with Dr. Jack Scannell

    In today's episode, we uncover the hidden crisis in the pharmaceutical industry as we explore the alarming state of R&D productivity. Our guest, Dr. Jack Scannell, is a renowned scientist and entrepreneur with extensive experience in both the biotech and investment fields. He shares his valuable insights into the concept of Eroom's Law, which reveals the inverse relationship between input efficiency and output efficiency in drug research and development.

    Listen in as we discuss the challenges of measuring R&D productivity and how financial return and number of drugs approved per unit input serve as key indicators of productivity. Dr. Scannell helps us understand the reasons behind the decline in R&D productivity since the 1950s and the factors that have contributed the most to this concerning trend.

    Don't miss this enlightening conversation that exposes the harsh reality of pharmaceutical R&D productivity, and be sure to share your thoughts and opinions by leaving a review or engaging with us on social media. We'd love to hear from you!

    Stay informed on the latest developments in pharmaceutical R&D productivity and other pressing global challenges by subscribing to our podcast. Your support helps us continue to bring you thought-provoking discussions and expert insights.

    Link to full episode

    ⏰ Timestamps
    00:00 Intro
    01:00 Jack Scannell Explains Eroom's Law

    💡 LINKS TO MORE CONTENT
    If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
    Watch on Youtube
    Jack Scannell
    Christian Soschner

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    14 min
  • SP 6: Saving the World from Extinction: A Review of Andy Weir's 'Project Hail Mary

    In this video, I review the science fiction novel "Project Hail Mary" by Andy Weir. As a fan of the genre, I was excited to dive into this action-packed and thought-provoking book that takes a critical look at some of the global issues we face today.

    I discuss the strengths and shortcomings of the book, as well as its potential pleasures and delights for science fiction enthusiasts. Join me as I explore the captivating story of Ryland Grace, a science teacher who wakes up alone in a spacecraft and must use his knowledge and skills to save the earth from an alien threat.

    Don't forget to leave a comment with your thoughts on the book and whether you would recommend it to others.

    💡 LINKS TO MORE CONTENT
    Buy the Book
    If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
    Podcast Episodes: https://pod.link/1493847125
    Check out our partners: https://linktr.ee/lsg2
    Watch on Youtube
    Christian Soschner

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    3 min
  • MM 1: Alex Zhavoronkov - Transforming Drug Discovery Forever: How AI Is Revolutionizing Medicine and Changing Lives!

    Welcome to our new series, Memorable Moments!

    In this series, we bring you highlights from past episodes that contain some of the most memorable insights and important information that you won't want to miss.

     In this episode, we explore the groundbreaking potential of AI in drug discovery and anti-aging research.

    Listen in as we share clips from our interview with Alex Zhavoronkov, who is leading the charge in this revolutionary technology that cuts costs, increases success rates, and drastically shortens the time it takes to develop new therapies.

    Join us as we share memorable moments and life-changing insights that will help you discover the incredible potential of the future of medicine. Don't miss out on this powerful and inspiring episode of our podcast - tune in now!

    Listen to the full episode

    ⏰ Timestamps
    00:00 Intro
    00:44 Alex Zhavoronkov Explains how his solution increases the probability of success, cuts costs and timelines in Drug Discovery and Development
    07:20 Shout out to our new subscribers on Buzzsprout+

    💡 LINKS TO MORE CONTENT
    If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
    Watch on Youtube
    Alex Zhavoronkov
    Christian Soschner
    Check out the organizations that make the podcast possible


    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    8 min
  • #108: Alex Zhavoronkov | Can AI Fix Drug Discovery?

    Can AI make drug discovery more likely to succeed?

    Alex Zhavoronkov believes that is the question that matters most. Faster chemistry and lower costs are valuable. But choosing better targets, designing better molecules and stopping weak programs earlier could change the economics of building a biotech company.

    In this conversation, the Insilico Medicine founder and CEO joins Christian Soschner from the World Government Summit in Dubai to explain how his team connects generative AI, biology and experimental validation.

    Alex walks through an idiopathic pulmonary fibrosis program that, he says, reached the preclinical candidate stage in under 18 months for under $3 million. He explains how Insilico combines target discovery with molecule design, why commercial strategy shapes scientific decisions, and where clinical trials still create bottlenecks.

    The conversation also explores his larger ambition: developing medicines that treat disease while addressing biological processes involved in aging.

    For biotech founders, investors and pharmaceutical leaders, this episode offers a practical way to think about AI: follow the evidence from a model’s prediction to a laboratory experiment, a development candidate and a clinical trial.

    WHAT YOU WILL LEARN

    • Why Alex prioritizes probability of success over speed and cost.
    • How generative AI connects target discovery and small molecule design.
    • What the fibrosis program reveals about the economics of early discovery.
    • How pharma’s future priorities influence pipeline decisions today.
    • Why robotics and experimental validation matter as much as algorithms.
    • How aging research could inform treatments for multiple diseases.

    CHAPTERS

    (00:00) Can AI change how we discover medicines?

    (02:07) Alex joins from the World Government Summit

    (04:21) Longevity, aging clocks and the search for new targets

    (08:22) How generative AI designs molecules

    (15:02) Drug discovery costs, productivity and failure

    (23:28) What Alex’s success estimates actually cover

    (24:50) The fibrosis program and an AI discovery case study

    (36:31) What the $3 million figure includes

    (38:09) Regulators and predicting clinical trial outcomes

    (40:33) Alex’s proposal for faster development

    (44:45) Rare diseases, recruitment and clinical bottlenecks

    (48:55) Audience question: AI and the microbiome

    (53:22) Building a global company around talent and research

    (57:34) Inside Insilico’s automated laboratory

    (01:01:39) Could a discovery lab fit into two rooms?

    (01:03:12) Medicines that address disease and aging

    (01:04:57) Life extension and the future of generative AI

    ABOUT THIS RECORDING

    Recorded in February 2023. Company milestones, pipeline status and forecasts reflect the conversation at that time. The cost and timeline figures describe a specific preclinical discovery program, rather than the full cost of developing an approved medicine.

    CONNECT AND EXPLORE

    Watch the conversation on YouTube

    Connect with Alex Zhavoronkov

    Explore Christian’s work and discuss working together

    Follow Beginner’s Mind for conversations about turning breakthrough science into companies that last.

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    1 hr 15 min
  • SP 5: Unleashing Your Creative Potential: Sol LeWitt's Timeless Advice to Eva Hesse

    Are you struggling with your creative process?

    Do you feel stuck in a rut or blocked by perfectionism? You're not alone. In this episode, I explore the remarkable letter from artist Sol LeWitt to Eva Hesse, which has inspired creatives for decades.

    Not only creatives can get stuck and blocked. Also, entrepreneurs, scientists, and investors can have to face such situations in their lives.

    Read by Benedict Cumberbatch for Letters Live at the Freemason's Hall in London, LeWitt's timeless advice urges us to stop overthinking and DO.

    Embrace the process, let go of perfectionism, and believe in your ability to create.

    Join me as I discover the wisdom of emptiness and how it can help you unleash your full potential. From conceptual art to minimalism, I delve into the fascinating lives of Sol LeWitt and Eva Hesse, two American artists who embarked on a supportive friendship that would inspire them both.

    So sit back, relax, and let's listen to the words of Sol LeWitt as read by Benedict Cumberbatch. This episode is a must-listen for anyone looking to break free from creative blocks and unleash their full potential.

    ⏰ Timestamps
    (00:00) Unleashing Your Creative Potential: The Remarkable Letter from Sol LeWitt to Eva Hesse Read by Benedict Cumberbatch
    (01:15) Background Information to Sol LeWitt, Eva Hesse, and their Inspiring Correspondence
    (04:00) Sol LeWitt's Timeless Advice to Eva Hesse: Stop Overthinking and Just DO
    (06:25) Perfectionism Kills Creativity
    (08:57) Embrace the Process, Don’t Focus on the Outcome
    (10:09) Believe in your ability to create

    💡 LINKS TO MORE CONTENT
    If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
    Podcast Episodes: https://pod.link/1493847125
    Check out our partners: https://linktr.ee/lsg2
    Watch on Youtube
    Christian Soschner

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    15 min